about
Allogenic banking of dental pulp stem cells for innovative therapeuticsConcise review: making and using clinically compliant pluripotent stem cell linesF4/80+ Host Macrophages Are a Barrier to Murine Embryonic Stem Cell-Derived Hematopoietic Progenitor Engraftment In Vivo.The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response.Towards a global human embryonic stem cell bank.Towards a global human embryonic stem cell bank: differential termination.Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model.Derivation and long-term culture of human parthenogenetic embryonic stem cells using human foreskin feeders.Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantationSingle-cell analysis of murine long-term hematopoietic stem cells reveals distinct patterns of gene expression during fetal migration.Gimme shelter: the immune system during pregnancy.Immunological considerations for embryonic and induced pluripotent stem cell banking.Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analysesComparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.The promise of human embryonic stem cells in aging-associated diseases.Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cellsNegligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts.Stem cells for murine interstitial cells of cajal suppress cellular immunity and colitis via prostaglandin E2 secretion.Safety of human embryonic stem cells in patients with terminal/incurable conditions- a retrospective analysis.Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes.Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans.Immunological Properties of Corneal Epithelial-Like Cells Derived from Human Embryonic Stem CellsPotential applications of intracellular antibodies (intrabodies) in stem cell therapeutics.Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies.Role of Keratinocyte Growth Factor in the Differentiation of Sweat Gland-Like Cells From Human Umbilical Cord-Derived Mesenchymal Stem CellsStrategies to improve non-viral vectors--potential applications in clinical transplantation.Neonatal desensitization supports long-term survival and functional integration of human embryonic stem cell-derived mesenchymal stem cells in rat joint cartilage without immunosuppression.Cardiovascular therapeutic aspects of cell therapy and stem cells.Immune response to stem cells and strategies to induce toleranceNeurodegeneration and cell replacement.Immunogenicity of pluripotent stem cells and their derivativesImmunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.Epigenetic dedifferentiation of somatic cells into pluripotency: cellular alchemy in the age of regenerative medicine?Therapeutic potentials of human embryonic stem cells in Parkinson's diseaseRegulatory issues for personalized pluripotent cells.Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging.The immune boundaries for stem cell based therapies: problems and prospective solutions.Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.The Role of Immunogenicity in Cardiovascular Disease.
P2860
Q26795542-89A31F3C-06C8-4357-ABF9-9611DB72EC04Q26852128-7CFDA33F-ADED-4198-AE91-F13AFC555F9CQ30828462-B4B554FC-D6CD-47BB-84D3-16D67B12F543Q33350218-D1C997B6-B043-4D0B-A4B4-796BB3457740Q33450344-F8839957-77D3-4B07-93FF-5B95F8256B6FQ33450354-DD8C6588-CC1B-4FCA-B2F4-31373C12D516Q33728871-88EB95F0-0666-4329-B500-9E1874B1BE69Q34038983-B775A030-4812-4459-9A84-AD95FCF50B70Q34124667-DC8ACD3E-2615-47B0-AF81-5E5EBCD810FFQ34140659-903C8FD6-1238-46D7-A41B-CA3544F329A7Q34177939-A7D7D2E2-E8B3-4368-BD8A-365D025A34F9Q34197332-71D644AC-1874-4ABE-AE62-3700B9D5A59FQ34769837-A5596653-18E8-44D2-91E7-9DAAB43B2275Q35100235-3CFDFD88-52A4-4C98-ACA3-D154647C4EFEQ35166105-2815B547-DAFD-4A0E-8E51-4140F17F88D9Q35473934-4C9E5287-3B61-4B54-B8B2-2F459C59788EQ35517873-6D24F281-2575-42EF-BB3E-FFCA7EF756F7Q35537116-9C6F078C-CE87-4745-B265-8FCBE557B466Q35784380-3630A8EB-1128-4141-8021-49FDF7254B34Q35794301-399F5C2D-2FB5-4626-8148-4EC147183061Q35900953-41583D75-1101-492A-A6BE-ED4B23A3E8C1Q35957485-CB0EE9FD-9F33-44DB-A308-D8DBCA57A55FQ36077406-D801BD86-CB0A-48DA-AF90-0553A1308475Q36321463-503FAC24-13F4-40E9-8AD8-D9D920E961EDQ36440745-C59F7684-3F6F-4BC1-A52A-FC1DD97C0E7BQ36481006-FED671C3-C32B-4391-8E9B-4A40021C9059Q36482263-7AED7562-705C-44E9-BA99-C0E7AD7F2399Q36667364-78050F1F-8123-4916-8B25-0288805DC0CAQ36737033-BE688892-0254-4861-BBB5-F3D01BD27F0CQ36748869-E9C6C49F-BE79-4E30-BE19-035CC5D8FDA6Q36802900-E706DD71-DA90-4CAB-8612-B51CDEA2ACC6Q36861712-919C2248-64B7-4526-B35E-38EFA0978AFDQ36956705-297165A1-9B4A-4674-BB81-8594E76CA7DAQ37131248-1D46CEC3-DBDD-4AF6-93AF-8E1170184658Q37217497-B61DC422-45F9-464B-BA52-A2A46F714468Q37240998-4EDAFB45-DD34-4A94-9EC3-7E548443A011Q37310625-2A3B60D7-EDF6-4038-A062-E8CA803FBB13Q37350071-C2B965D4-3760-446B-B7E4-7BF0C1569AC6Q37398305-F0757C8C-20F7-4D34-8F5C-06FB12D69BECQ37560012-4FC31E56-9625-497F-BF6D-62968D15D0EC
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Stem cell medicine encounters the immune system.
@ast
Stem cell medicine encounters the immune system.
@en
Stem cell medicine encounters the immune system.
@nl
type
label
Stem cell medicine encounters the immune system.
@ast
Stem cell medicine encounters the immune system.
@en
Stem cell medicine encounters the immune system.
@nl
prefLabel
Stem cell medicine encounters the immune system.
@ast
Stem cell medicine encounters the immune system.
@en
Stem cell medicine encounters the immune system.
@nl
P356
P1476
Stem cell medicine encounters the immune system.
@en
P2093
J Andrew Bradley
Roger A Pedersen
P304
P356
10.1038/NRI934
P577
2002-11-01T00:00:00Z